tm logo
LOGICA
Live/Registered
REGISTERED

on 19 Sep 2023

Last Applicant/ Owned by

251 Ballardvale Street

Wilmington

MA

01887

Serial Number

97376850 filed on 22nd Apr 2022

Registration Number

7171333 registered on 19th Sep 2023

in the Principal Register

Correspondent Address

Joseph V. Myers III

Joseph V. Myers III

1075 PEACHTREE ST. NE

SUITE 2500

ATLANTA, GA 30309

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LOGICA

Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using artificial intelligence; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using machine learning; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using artificial intelligence; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using machine learning; Pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing chemical lead series or lead compounds via software using artificial intelligence, machine learning, computational modeling, DNA-encoded library screening platform, high-throughput screening, medicinal chemistry, ADME, biology, pharmacology and/or non-GLP safety testing


First Use Date in General

27th Apr 2022

First Use Date in Commerce

27th Apr 2022

Mark Details


Serial Number

No 97376850

Mark Type

No Service Mark

Attorney Docket Number

No 057670

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Sep 2023REGISTERED-PRINCIPAL REGISTER
19th Sep 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Aug 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Aug 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18th Jul 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
18th Jul 2023STATEMENT OF USE PROCESSING COMPLETE
21st Jun 2023TEAS STATEMENT OF USE RECEIVED
21st Jun 2023USE AMENDMENT FILED
31st Jan 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06th Dec 2022PUBLISHED FOR OPPOSITION